REVELATION BIOSCIENCES, INC.
REVBDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How REVB's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Intravenous Gemini | Phase 2 | Renal Insufficiency, Chronic | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in REVELATION BIOSCIENCES, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in REVELATION BIOSCIENCES, INC.'s (REVB) pipeline across Phase 2. Its lead program is Intravenous Gemini (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is REVELATION BIOSCIENCES, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for REVELATION BIOSCIENCES, INC. (REVB) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track REVB biotech catalysts?→
Add REVB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow REVELATION BIOSCIENCES, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.